Subscribe Now!

 

Sunday, December 5, 2021

Crozer-Keystone Participates in Largest Brain Amyloid Scan Research Study

Hellenic News
Hellenic News
The copyrights for these articles are owned by HNA. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of HNA and its representatives.

Latest articles

GREECE; Black Friday online sales up 119%, survey says

Online sales during the Black Friday period were up compared with the rest of the year, a survey by Generation Y-International eBusiness Hub said...

GREECE; First case of ‘Omicron’ variant detected in Crete

The first case of the Omicron variant of the novel coronavirus has been identified in Greece, Health Minister Thanos Plevris confirmed on Thursday during...

Νέα επιχειρηματικότητα: Πώς αντιμετωπίζει τις προκλήσεις της εποχής και τις δυσκολίες ένας νέος Καρδιτσιώτης επιχειρηματίας

Με αισιοδοξία, όραμα και αποφασιστικές κινήσεις αντιμετωπίζουν κάθε δυσκολία νέοι Έλληνες επιχειρηματίες, κάτι που δεν σταμάτησαν να κάνουν ούτε στη διάρκεια της δεκαετούς οικονομικής...

Επένδυση με κριτήρια ESG: Η ευκαιρία για τις ελληνικές επιχειρήσεις

Ο ταχύς μετασχηματισμός της ελληνικής οικονομίας και των επιχειρήσεων, μέσω της πράσινης και ψηφιακής μετάβασης, σε ένα νέο παραγωγικό μοντέλο, στη βάση των προτύπων...

Διαδρομές πολιτιστικού και τουριστικού ενδιαφέροντος, στην Αθήνα, με πρόσβαση για ανθρώπους με κινητική ή οπτική αναπηρία

Στην πιλοτική καταγραφή διαδρομών πολιτιστικού και τουριστικού ενδιαφέροντος στην πρωτεύουσα, διαδρομών προσβάσιμων για ανθρώπους με κινητική ή οπτική αναπηρία, προχωρά ο Δήμος Αθηναίων. Ήδη, σε...

“Η μεγάλη ευκαιρία της Ελλάδος να κάνει το άλμα -Το επενδυτικό ενδιαφέρον γίνεται πράξη”

Υπάρχουν όλες οι προϋποθέσεις η Ελλάδα να κάνει το μεγάλο άλμα στον τομέα της οικονομίας και των επενδύσεων, αναφέρει ο γενικός διευθυντής του Ελληνοαμερικανικού...

“Η συνεργασία Ελλάδας-ΗΠΑ υποστηρίζει την ειρήνη και τη σταθερότητα στην Αν. Μεσόγειο”

«Η Ελλάδα αποτελεί αξιόπιστο, ισχυρό και συνεπή σύμμαχο και πυλώνα σταθερότητας στην ευρύτερη περιοχή της Αν. Μεσογείου, της Μέσης Ανατολής και της Βόρειας Αφρικής....

Crozer-Keystone Participates in Largest Brain Amyloid Scan Research Study

Medicare to Cover Eligible Seniors for Amyloid PET Scans in Diagnosis of Alzheimer’s, Dementia

SPRINGFIELD, Pa. — Crozer-Keystone Health System is now a registered amyloid positron emission tomography (PET) imaging site in the $100 million Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study (Ideas-Study.org). Crozer-Keystone can offer Medicare-covered amyloid PET scans to study eligible Medicare patients who are referred by participating IDEAS dementia specialists (neurologists, psychiatrists and geriatric medicine physicians). The research study seeks to determine the clinical usefulness of PET imaging of brain amyloid deposits in the diagnosis of patients who are being evaluated for Alzheimer’s disease and dementia.

“Medicare will only cover these exams for seniors if done as part of clinical trial or data registry,” says William S. Zirker, M.D., MPH, chief of the Divisions of Geriatrics at Crozer-Chester Medical Center. “Currently, no private insurer covers amyloid PET scans for patients being evaluated for dementia or memory loss. I encourage local participating dementia specialists to refer eligible patients to the Center for Geriatric Medicine to get Medicare-covered amyloid PET scans that may better inform their care and future Alzheimer’s diagnosis and treatment.” The Center for Geriatric Medicine is staffed by a team of board-certified, fellowship-trained geriatricians and offers a full-range of primary care and consultative services for older adults.

Diagnosing Alzheimer’s disease is complex. With no single test currently available, diagnosis is based on an individual’s history, physical examination and cognitive testing. Amyloid PET imaging represents a potential major advance in the assessment of people with cognitive impairment. The scan visualizes plaques present in the brain that are prime suspects in damaging and killing nerve cells in Alzheimer’s patients. Before amyloid PET, these plaques could only be detected by examining the brain at autopsy. The IDEAS Study will follow Medicare beneficiaries to determine if amyloid PET scans may help physicians make more informed treatment decisions.

Thanks for reading Hellenic News of America

“There has never been a study of this scale to evaluate the clinical value of brain amyloid imaging in diagnosing and caring for those affected by Alzheimer’s,” says Maria Carrillo, Ph.D., Alzheimer’s Association chief science officer and IDEAS Study investigator. The dementia specialists and facilities that register for the IDEAS Study will play an essential role in engaging the nearly 19,000 individuals needed in the study and carrying out the amyloid PET scans.”

“Our participation in this landmark study solidifies Crozer-Keystone’s longtime position as a leader in the care of dementing diseases,” says Kevin Caputo, M.D., chair of Psychiatry and vice president of Behavioral Health for Crozer-Keystone Health System. “As a psychiatrist, I work hand-in-hand with our geriatricians to provide the best care possible to those with Alzheimer’s or other dementing disorders – and their caregivers. It is exciting to see our specialists involved in a study that can dramatically alter and improve the way we treat this devastating disease. It gives hope to our community, our patients, and those who care for and about them.”

Patients cannot directly enroll in the IDEAS Study. IDEAS Study dementia specialists must enroll patients whose cases meet the study criteria and refer them to registered PET imaging facilities, such as Crozer-Keystone’s, for an amyloid PET scan. These scans will be performed and interpreted by a nuclear medicine physician or radiologist who is registered to take part in the IDEAS Study. Results will be provided to the ordering doctor for disclosure to the patient and to support further diagnostic decisions. Scan results and diagnosis will be captured for the study.

The IDEAS Study is sponsored by the American College of Radiology (ACR) and American College of Radiology Imaging Network (ACRIN), with funding and direction provided by the Alzheimer’s Association, the ACR and the manufacturers of the FDA-approved radiopharmaceuticals for amyloid imaging.

Registered dementia specialists interested in referring enrolled patients to the Crozer-Keystone Center for Geriatric Medicine can call 610-338-2722.

###

Photo caption: William Zirker, M.D., MPH, chief of the Division of Geriatrics, Crozer-Keystone Health System.

The copyrights for these articles are owned by the Hellenic News of America. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of the Hellenic News of America and its representatives.

Get Access Now!